Predictive Value of the CES-D in Detecting Depression Among Candidates for Disease-Modifying Multiple Sclerosis Treatment
- 1 March 2005
- journal article
- research article
- Published by Elsevier in Psychosomatics
- Vol. 46 (2) , 131-134
- https://doi.org/10.1176/appi.psy.46.2.131
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Interferon β1a and depression in secondary progressive MS: Data from the SPECTRIMS TrialNeurology, 2002
- Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple SclerosisNew England Journal of Medicine, 2000
- Biopsychosocial correlates of lifetime major depression in a multiple sclerosis populationMultiple Sclerosis Journal, 2000
- Treatment of Depression Improves Adherence to Interferon Beta-1b Therapy for Multiple SclerosisArchives of Neurology, 1997
- Depression and multiple sclerosisNeurology, 1996
- Depression in multiple sclerosisGeneral Hospital Psychiatry, 1987
- Mood Disorder and Multiple SclerosisArchives of Neurology, 1987
- Depressive episodes in patients with multiple sclerosisAmerican Journal of Psychiatry, 1983
- ASSESSING DEPRESSIVE SYMPTOMS IN FIVE PSYCHIATRIC POPULATIONS: A VALIDATION STUDYAmerican Journal of Epidemiology, 1977
- The CES-D ScaleApplied Psychological Measurement, 1977